More info, easier access
Docphin: the Best New iOS App for Medical Professionals in 2014
Docphin is rapidly becoming the most popular of a number of new and improved medical data retrieval apps. It gives you access to more than 5000 medical journals, includes a “medstream” of late breaking news, Twitter feeds and more.
The app is now used by more than 400 institutions in 15 countries with new hospitals and universities steadily joining the ranks. In Canada, members include UBC, U of T, the University of Ottawa, McGill and Dalhousie.
The “phin” in Docphin stands for Personalized Heath Information Network which you create, and which then forwards content pertinent to your interests and shows what’s trending among your colleagues.
It’s simple to use and widgets make it easy to customize sources. For example, you can opt to search only PDFs or free articles. Journals can be accessed by name, the title of an article and/or author. Further search results can be filtered by publication year, medical specialty and type of publication (clinical trial, review article etc.).
Content is kept up-to-date by a team of medical consultants called Ambassadors who determine which journals would be most useful to a given specialty group.
5000 medical journals
Alerts of breaking news in areas you select (can be turned off and on)
Articles that can be shared with others or saved for later view
Content that can be shared via email, Twitter or Facebook
Search page includes clinical guidelines
Customized Twitter feeds that follow societies and experts from over 20 specialties
Information that can be managed in RSS feeds
Selected by Apple as the best iOS medical app in 2014
Developed by a group of entrepreneurial physicians
Devices: iPhone, iPad and Android
Cost: free, but you have to be affiliated with a member institution for access. For participants and to sign up go to docphin.com. If your institution isn’t listed, Docphin will undertake to sign them up.
This article was accurate when it was published. Please confirm rates and details directly with the companies in question.